Prenatal diagnosis for facioscapulohumeral muscular dystrophy (FSHD).
This study outlines the molecular DNA findings derived from 12 separate prenatal diagnoses offered to families with a history of facioscapulohumeral muscular dystrophy. A high risk of the fetus being affected was identified in five pregnancies. Several practical problems are discussed, particularly those arising from the quality and quantity of DNA made available for molecular diagnosis. Evidence of the 4q35 and 10q26 telomeric exchanges is present in 20 per cent of the general population and the specificity of the test is 95 per cent. The eventual isolation and functional characterization of the FSHD gene should allow us to unravel many of the complexities currently associated with the molecular diagnosis of this disorder.
Upadhyaya
M
M
Institute of Medical Genetics, Heath Park, Cardiff CF4 4XW, U.K. wmgmu@cardiff.ac.uk
MacDonald
M
M
Ravine
D
D
D002879:Chromosomes, Human, Pair 10; D002894:Chromosomes, Human, Pair 4; D004247:DNA / Q000235:genetics; D005260:Female; D005820:Genetic Testing; D006801:Humans; D008297:Male; D020391:Muscular Dystrophy, Facioscapulohumeral / Q000175:diagnosis* / Q000235:genetics; D010375:Pedigree; D011296:Prenatal Diagnosis / Q000379:methods*; D012680:Sensitivity and Specificity
D004247:DNA